A melanoma vaccine has been found to reduce the risk of cancer recurrence or death by 49 per cent over three years, researchers have found..
A melanoma vaccine has been found to reduce the risk of cancer recurrence or death by 49 per cent over three years, researchers have found.
A melanoma vaccine has been found to reduce the risk of cancer recurrence or death by 49 per cent over three years, researchers have found..